Obstructive Sleep Apnea: Role of Intermittent Hypoxia and Inflammation

Abstract

Obstructive sleep apnea results in intermittent hypoxia via repetitive upper airway obstruction leading to partial or complete upper airway closure, apneas and hypopneas, respectively. Intermittent hypoxia leads to sympathetic nervous system activation and oxidative stress with a resultant systemic inflammatory cascade. The putative mechanism by which obstructive sleep apnea has been linked to numerous pathologic conditions including stoke, cardiovascular disease, hypertension, and metabolic derangements is through these systemic effects. Treatment of obstructive sleep apnea appears to reduce systemic markers of inflammation and ameliorates the adverse sequelae of this disease.

Keywords

obstructive sleep apnea - inflammation - intermittent hypoxia - sympathetic nervous system activation

• References

• 1 Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22 (5) 667-689
• 2 Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9) 1006-1014
• 3 Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ 2009; 108 (5) 246-249
• 4 Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J 2009; 33 (4) 907-914
• 5 Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med 2010; 11 (5) 441-446
• 6 Quintana-Gallego E, Carmona-Bernal C, Capote F , et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 2004; 98 (10) 984-989
• 7 Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291 (16) 2013-2016
• 8 Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284 (23) 3015-3021
• 9 Li KK, Kushida C, Powell NB, Riley RW, Guilleminault C. Obstructive sleep apnea syndrome: a comparison between Far-East Asian and white men. Laryngoscope 2000; 110 (10, Pt 1) 1689-1693
• 10 Bixler EO, Vgontzas AN, Lin HM , et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163 (3, Pt 1) 608-613
• 11 Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003; 167 (9) 1181-1185
• 12 Redline S, Tishler PV. The genetics of sleep apnea. Sleep Med Rev 2000; 4 (6) 583-602
• 13 Mehra R, Xu F, Babineau DC , et al. Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010; 182 (6) 826-833
• 14 Mody P, Rukhadze I, Kubin L. Rats subjected to chronic-intermittent hypoxia have increased density of noradrenergic terminals in the trigeminal sensory and motor nuclei. Neurosci Lett 2011; 505 (2) 176-179
• 15 Rukhadze I, Fenik VB, Benincasa KE, Price A, Kubin L. Chronic intermittent hypoxia alters density of aminergic terminals and receptors in the hypoglossal motor nucleus. Am J Respir Crit Care Med 2010; 182 (10) 1321-1329
• 16 Prabhakar NR, Kumar GK. Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 2004; 385 (3-4) 217-221
• 17 Kumar GK, Rai V, Sharma SD , et al. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 2006; 575 (Pt 1) 229-239
• 18 Souvannakitti D, Kumar GK, Fox A, Prabhakar NR. Contrasting effects of intermittent and continuous hypoxia on low O(2) evoked catecholamine secretion from neonatal rat chromaffin cells. Adv Exp Med Biol 2009; 648: 345-349
• 19 Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103 (6) 1763-1768
• 20 Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007; 176 (7) 706-712
• 21 Rossi VA, Stradling JR, Kohler M. Effects of obstructive sleep apnoea on heart rhythm. Eur Respir J 2013; 41 (6) 1439-1451
• 22 Can M, Açikgöz S, Mungan G , et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006; 129 (2) 233-237
• 23 Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 2005; 46 (5) 801-809
• 24 Shamsuzzaman AS, Winnicki M, Lanfranchi P , et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105 (21) 2462-2464
• 25 Yokoe T, Minoguchi K, Matsuo H , et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107 (8) 1129-1134
• 26 Barceló A, Barbé F, Llompart E , et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004; 117 (2) 118-121
• 27 Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004; 27 (8) 1507-1511
• 28 Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007; 62 (6) 509-514
• 29 Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP)—no association with sleep duration or sleep disordered breathing. Sleep 2007; 30 (8) 991-996
• 30 Steiropoulos P, Tsara V, Nena E , et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2007; 132 (3) 843-851
• 31 Akashiba T, Akahoshi T, Kawahara S, Majima T, Horie T. Effects of long-term nasal continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea syndrome. Intern Med 2005; 44 (8) 899-900
• 32 Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004; 28 (2) 87-91
• 33 Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008; 134 (4) 686-692
• 34 Minoguchi K, Tazaki T, Yokoe T , et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004; 126 (5) 1473-1479
• 35 Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006; 174 (7) 824-830
• 36 Alzoghaibi MA, Bahammam AS. Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath 2005; 9 (3) 119-126
• 37 Li C, Zhang XL, Liu H, Wang ZG, Yin KS. Association among plasma interleukin-18 levels, carotid intima- media thickness and severity of obstructive sleep apnea. Chin Med J (Engl) 2009; 122 (1) 24-29
• 38 Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol (1985) 2003; 94 (1) 179-184
• 39 Mehra R, Storfer-Isser A, Kirchner HL , et al. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 2006; 166 (16) 1725-1731
• 40 Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997; 82 (5) 1313-1316
• 41 El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002; 121 (5) 1541-1547
• 42 Ohga E, Nagase T, Tomita T , et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol (1985) 1999; 87 (1) 10-14
• 43 Ursavaş A, Karadağ M, Rodoplu E, Yilmaztepe A, Oral HB, Gözü RO. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 2007; 74 (5) 525-532
• 44 Zamarrón-Sanz C, Ricoy-Galbaldon J, Gude-Sampedro F, Riveiro-Riveiro A. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res 2006; 37 (4) 552-555
• 45 Chin K, Nakamura T, Shimizu K , et al. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000; 109 (7) 562-567
• 46 Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59 (9) 777-782
• 47 Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995; 108 (3) 625-630
• 48 Eisensehr I, Ehrenberg BL, Noachtar S , et al. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998; 51 (1) 188-195
• 49 Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16 (4) 648-652
• 50 Chin K, Ohi M, Kita H , et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996; 153 (6, Pt 1) 1972-1976
• 51 Peled N, Kassirer M, Kramer MR , et al. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res 2008; 121 (5) 631-636
• 52 Phillips CL, McEwen BJ, Morel-Kopp MC , et al. Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax 2012; 67 (7) 639-644
• 53 von Känel R, Natarajan L, Ancoli-Israel S , et al. Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med 2013; 14 (1) 58-65
• 54 Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162 (6) 2039-2042
• 55 Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review. World J Diabetes 2013; 4 (6) 238-244
• 56 Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol 1999; 19 (4) 972-978
• 57 Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta 2013; 417: 80-84
• 58 Polotsky VY, Li J, Punjabi NM , et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003; 552 (Pt 1) 253-264
• 59 Drager LF, Li J, Reinke C, Bevans-Fonti S, Jun JC, Polotsky VY. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring) 2011; 19 (11) 2167-2174
• 60 Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118 (3) 580-586
• 61 Cuhadaroğlu C, Utkusavaş A, Oztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009; 187 (2) 75-81
• 62 Chin K, Shimizu K, Nakamura T , et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999; 100 (7) 706-712
• 63 Iiyori N, Alonso LC, Li J , et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 2007; 175 (8) 851-857
• 64 Chan SL, Perrett CW, Morgan NG. Differential expression of alpha 2-adrenoceptor subtypes in purified rat pancreatic islet A- and B-cells. Cell Signal 1997; 9 (1) 71-78
• 65 Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985) 2009; 106 (5) 1538-1544
• 66 Furukawa S, Fujita T, Shimabukuro M , et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114 (12) 1752-1761
• 67 Louis M, Punjabi NM. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol (1985) 2009; 106 (5) 1538-1544
• 68 Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009; 122 (12) 1122-1127
• 69 Strohl KP, Novak RD, Singer W , et al. Insulin levels, blood pressure and sleep apnea. Sleep 1994; 17 (7) 614-618
• 70 Vgontzas AN, Papanicolaou DA, Bixler EO , et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85 (3) 1151-1158
• 71 Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165 (5) 670-676
• 72 Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160 (6) 521-530
• 73 Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172 (12) 1590-1595
• 74 Togeiro SM, Carneiro G, Ribeiro Filho FF , et al. Consequences of obstructive sleep apnea on metabolic profile: a Population-Based Survey. Obesity (Silver Spring) 2013; 21 (4) 847-851
• 75 Stamatakis K, Sanders MH, Caffo B , et al. Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep 2008; 31 (7) 1018-1024
• 76 Iftikhar IH, Khan MF, Das A, Magalang UJ. Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes. Ann Am Thorac Soc 2013; 10 (2) 115-120
• 77 West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007; 62 (11) 969-974
• 78 Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29 (4) 720-727
• 79 Vgontzas AN, Zoumakis E, Bixler EO , et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008; 38 (8) 585-595
• 80 Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest 1982; 69 (6) 1286-1292
• 81 Lesske J, Fletcher EC, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia—influence of chemoreceptors and sympathetic nervous system. J Hypertens 1997; 15 (12, Pt 2) 1593-1603
• 82 Iturriaga R, Rey S, Del Río R. Cardiovascular and ventilatory acclimatization induced by chronic intermittent hypoxia: a role for the carotid body in the pathophysiology of sleep apnea. Biol Res 2005; 38 (4) 335-340
• 83 Kanagala R, Murali NS, Friedman PA , et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107 (20) 2589-2594
• 84 Allahdadi KJ, Cherng TW, Pai H , et al. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 2008; 295 (1) H434-H440
• 85 Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98 (11) 1071-1077
• 86 Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001; 37 (2, Pt 2) 511-515
• 87 Marcus NJ, Olson Jr EB, Bird CE, Philippi NR, Morgan BJ. Time-dependent adaptation in the hemodynamic response to hypoxia. Respir Physiol Neurobiol 2009; 165 (1) 90-96
• 88 Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 2007; 293 (5) H2971-H2976
• 89 Patel D, Mohanty P, Di Biase L , et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 2010; 3 (5) 445-451
• 90 Fein AS, Shvilkin A, Shah D , et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62 (4) 300-305
• 91 Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care 2010; 55 (10) 1333-1344 , discussion 1344–1346
• 92 Friedman JK, Nitta CH, Henderson KM , et al. Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 incrasing endothelin-1 vasoconstrictor reactivity. Vascul Pharmacol 2014; 60 (1) 17-24
• 93 Leung RS. Sleep-disordered breathing: autonomic mechanisms and arrhythmias. Prog Cardiovasc Dis 2009; 51 (4) 324-338
• 94 Liu LC, Damman K, Lipsic E, Maass AH, Rienstra M, Westenbrink BD. Heart failure highlights in 2012-2013. Eur J Heart Fail 2014; 16 (2) 122-132
• 95 Chugh SS, Havmoeller R, Narayanan K , et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129 (8) 837-847
• 96 Rienstra M, Yin X, Larson MG , et al. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Am Heart J 2014; 167 (1) 109-115 , e2
• 97 Pedrosa RP, Drager LF, Gonzaga CC , et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011; 58 (5) 811-817
• 98 Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension: an update. Hypertension 2014; 63 (2) 203-209
• 99 Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342 (19) 1378-1384
• 100 Nieto FJ, Young TB, Lind BK , et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283 (14) 1829-1836
• 101 Haentjens P, Van Meerhaeghe A, Moscariello A , et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167 (8) 757-764
• 102 Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; (3) CD001106
• 103 Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012; 8 (5) 587-596
• 104 Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50 (2) 417-423
• 105 Alajmi M, Mulgrew AT, Fox J , et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185 (2) 67-72
• 106 Pepperell JC, Ramdassingh-Dow S, Crosthwaite N , et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359 (9302) 204-210
• 107 Pedrosa RP, Drager LF, de Paula LK, Amaro AC, Bortolotto LA, Lorenzi-Filho G. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest 2013; 144 (5) 1487-1494
• 108 Martínez-García MA, Capote F, Campos-Rodríguez F , et al; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013; 310 (22) 2407-2415
• 109 Chobanian AV, Bakris GL, Black HR , et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19) 2560-2572
• 110 Lévy P, Pépin JL, Arnaud C, Baguet JP, Dematteis M, Mach F. Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 2009; 51 (5) 400-410
• 111 Savransky V, Nanayakkara A, Li J , et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007; 175 (12) 1290-1297
• 112 Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45 (4) 705-709
• 113 Lefebvre B, Godin-Ribuot D, Joyeux-Faure M , et al. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 2006; 150 (2-3) 278-286
• 114 Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169 (3) 348-353
• 115 Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96 (5) 1432-1437
• 116 Nadeem R, Harvey M, Singh M , et al. Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis. Int J Vasc Med 2013; 2013: 839582
• 117 Chambless LE, Folsom AR, Clegg LX , et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000; 151 (5) 478-487
• 118 Chambless LE, Heiss G, Folsom AR , et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146 (6) 483-494
• 119 Hodis HN, Mack WJ, LaBree L , et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128 (4) 262-269
• 120 O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK. Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340 (1) 14-22
• 121 Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11 (5) 1245-1249
• 122 Kuniyoshi FH, Garcia-Touchard A, Gami AS , et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008; 52 (5) 343-346
• 123 Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352 (12) 1206-1214
• 124 Cuspidi C, Meani S, Valerio C, Fusi V, Zanchetti A. Nocturnal non-dipping pattern in untreated hypertensives at different cardiovascular risk according to the 2003 ESH/ESC guidelines. Blood Press 2006; 15 (1) 37-44
• 125 Eguchi K, Pickering TG, Hoshide S , et al. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without type 2 diabetes. Am J Hypertens 2008; 21 (4) 443-450
• 126 Gorostidi M, Sobrino J, Segura J , et al; Spanish Society of Hypertension ABPM Registry investigators. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens 2007; 25 (5) 977-984
• 127 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464) 1046-1053
• 128 Lavie P, Herer P, Peled R , et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18 (3) 149-157
• 129 Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50 (14) 1310-1314
• 130 Milleron O, Pillière R, Foucher A , et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004; 25 (9) 728-734
• 131 Gottlieb DJ, Yenokyan G, Newman AB , et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010; 122 (4) 352-360
• 132 Chan J, Sanderson J, Chan W , et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997; 111 (6) 1488-1493
• 133 Wang HQ, Chen G, Li J , et al. Subjective sleepiness in heart failure patients with sleep-related breathing disorder. Chin Med J (Engl) 2009; 122 (12) 1375-1379
• 134 Ferrier K, Campbell A, Yee B , et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005; 128 (4) 2116-2122
• 135 Javaheri S, Parker TJ, Liming JD , et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97 (21) 2154-2159
• 136 Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160 (4) 1101-1106
• 137 Vazir A, Hastings PC, Dayer M , et al. A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9 (3) 243-250
• 138 Serizawa T, Vogel WM, Apstein CS, Grossman W. Comparison of acute alterations in left ventricular relaxation and diastolic chamber stiffness induced by hypoxia and ischemia. Role of myocardial oxygen supply-demand imbalance. J Clin Invest 1981; 68 (1) 91-102
• 139 Sano K, Watanabe E, Hayano J , et al. Central sleep apnoea and inflammation are independently associated with arrhythmia in patients with heart failure. Eur J Heart Fail 2013; 15 (9) 1003-1010
• 140 Liu JN, Zhang JX, Lu G , et al. The effect of oxidative stress in myocardial cell injury in mice exposed to chronic intermittent hypoxia. Chin Med J (Engl) 2010; 123 (1) 74-78
• 141 Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005; 172 (7) 915-920
• 142 Hayashi T, Yamashita C, Matsumoto C , et al. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol 2008; 294 (5) H2197-H2203
• 143 Parker JD, Brooks D, Kozar LF , et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 1999; 160 (6) 1888-1896
• 144 Wang H, Parker JD, Newton GE , et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 49 (15) 1625-1631
• 145 Kasai T, Narui K, Dohi T , et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008; 133 (3) 690-696
• 146 Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112 (3) 375-383
• 147 Kahwash R, Kikta D, Khayat R. Recognition and management of sleep-disordered breathing in chronic heart failure. Curr Heart Fail Rep 2011; 8 (1) 72-79
• 148 Bradley TD, Logan AG, Kimoff RJ , et al; CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353 (19) 2025-2033
• 149 Arzt M, Floras JS, Logan AG , et al; CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115 (25) 3173-3180
• 150 Yuan G, Nanduri J, Khan S, Semenza GL, Prabhakar NR. Induction of HIF-1alpha expression by intermittent hypoxia: involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 2008; 217 (3) 674-685
• 151 Dudley Jr SC, Hoch NE, McCann LA , et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005; 112 (9) 1266-1273
• 152 Bayés de Luna A, Bayés Genís A, Guindo J , et al. Mechanisms favoring and triggering atrial fibrillation [in French]. Arch Mal Coeur Vaiss 1994; 87 (1 Spec No) 19-25
• 153 Tse HF, Lau CP. Electrophysiological properties of the fibrillating atrium: implications for therapy. Clin Exp Pharmacol Physiol 1998; 25 (5) 293-302
• 154 Lin YK, Lai MS, Chen YC , et al. Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. Clin Sci (Lond) 2012; 122 (3) 121-132
• 155 Mehra R, Benjamin EJ, Shahar E , et al; Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173 (8) 910-916
• 156 Mehra R, Stone KL, Varosy PD , et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med 2009; 169 (12) 1147-1155
• 157 Gami AS, Hodge DO, Herges RM , et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49 (5) 565-571
• 158 Leung RS, Comondore VR, Ryan CM, Stevens D. Mechanisms of sleep-disordered breathing: causes and consequences. Pflugers Arch 2012; 463 (1) 213-230
• 159 Simantirakis EN, Schiza SI, Marketou ME , et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 2004; 25 (12) 1070-1076
• 160 Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118 (3) 591-595
• 161 Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52 (5) 490-494
• 162 Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90 (1) 47-112
• 163 Niijima M, Kimura H, Edo H , et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1999; 159 (6) 1766-1772
• 164 Marrone O, Bonsignore MR, Romano S, Bonsignore G. Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea. Eur Respir J 1994; 7 (12) 2192-2198
• 165 Schäfer H, Hasper E, Ewig S , et al. Pulmonary haemodynamics in obstructive sleep apnoea: time course and associated factors. Eur Respir J 1998; 12 (3) 679-684
• 166 Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006; 99 (7) 675-691
• 167 Campen MJ, Shimoda LA, O'Donnell CP. Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol (1985) 2005; 99 (5) 2028-2035
• 168 Fagan KA. Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia. J Appl Physiol (1985) 2001; 90 (6) 2502-2507
• 169 Nisbet RE, Graves AS, Kleinhenz DJ , et al. The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Respir Cell Mol Biol 2009; 40 (5) 601-609
• 170 Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis 2009; 51 (5) 363-370
• 171 Bradley TD, Rutherford R, Grossman RF , et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985; 131 (6) 835-839
• 172 Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996; 109 (2) 380-386
• 173 Krieger J, Sforza E, Apprill M, Lampert E, Weitzenblum E, Ratomaharo J. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989; 96 (4) 729-737
• 174 Weitzenblum E, Chaouat A. Obstructive sleep apnea syndrome and the pulmonary circulation. Ital Heart J 2005; 6 (10) 795-798
• 175 Weitzenblum E, Krieger J, Apprill M , et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988; 138 (2) 345-349
• 176 Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou JB. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001; 68 (6) 566-572
• 177 Sanner BM, Doberauer C, Konermann M, Sturm A, Zidek W. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997; 157 (21) 2483-2487
• 178 Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27 (9) 1106-1113
• 179 Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban JP. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 2000; 55 (11) 934-939
• 180 Hetzel M, Kochs M, Marx N , et al. Pulmonary hemodynamics in obstructive sleep apnea: frequency and causes of pulmonary hypertension. Lung 2003; 181 (3) 157-166
• 181 Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994; 149 (2, Pt 1) 416-422
• 182 Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Douglas Mcevoy R. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med 1999; 159 (5, Pt 1) 1518-1526
• 183 Sajkov D, Wang T, Saunders NA, Bune AJ, Mcevoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165 (2) 152-158
• 184 Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151 (1) 82-86
• 185 Ganga HV, Nair SU, Puppala VK, Miller WL. Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study. J Geriatr Cardiol 2013; 10 (2) 129-134
• 186 Owens RL, Malhotra A, Eckert DJ, White DP, Jordan AS. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. J Appl Physiol (1985) 2010; 108 (2) 445-451
• 187 Nadel JA, Widdicombe JG. Reflex effects of upper airway irritation on total lung resistance and blood pressure. J Appl Physiol 1962; 17: 861-865
• 188 Resta O, Foschino Barbaro MP, Brindicci C, Nocerino MC, Caratozzolo G, Carbonara M. Hypercapnia in overlap syndrome: possible determinant factors. Sleep Breath 2002; 6 (1) 11-18
• 189 Thun MJ, Carter BD, Feskanich D , et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368 (4) 351-364
• 190 Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182 (3) 325-331
• 191 Machado MC, Vollmer WM, Togeiro SM , et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010; 35 (1) 132-137
• 192 Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 2000; 22 (1) 21-27
• 193 Harbison J, Gibson GJ, Birchall D, Zammit-Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute stroke. Neurology 2003; 61 (7) 959-963
• 194 Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6 (2) 131-137
• 195 Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353 (19) 2034-2041
• 196 Mooe T, Franklin KA, Holmström K, Rabben T, Wiklund U. Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001; 164 (10, Pt 1) 1910-1913
• 197 Redline S, Yenokyan G, Gottlieb DJ , et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010; 182 (2) 269-277
• 198 Li M, Hou WS, Zhang XW, Tang ZY. Obstructive sleep apnea and risk of stroke: a meta-analysis of prospective studies. Int J Cardiol 2014; 172 (2) 466-469
• 199 Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97 (1) 27-32
• 200 Ryan CM, Bayley M, Green R, Murray BJ, Bradley TD. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011; 42 (4) 1062-1067
• 201 Bravata DM, Concato J, Fried T , et al. Continuous positive airway pressure: evaluation of a novel therapy for patients with acute ischemic stroke. Sleep 2011; 34 (9) 1271-1277
• 202 Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L , et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009; 180 (1) 36-41
• 203 Xie H, Yung WH. Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor. Acta Pharmacol Sin 2012; 33 (1) 5-10
• 204 Bucks RS, Olaithe M, Eastwood P. Neurocognitive function in obstructive sleep apnoea: a meta-review. Respirology 2013; 18 (1) 61-70
• 205 Gozal D, Daniel JM, Dohanich GP. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 2001; 21 (7) 2442-2450
• 206 Row BW, Kheirandish L, Neville JJ, Gozal D. Impaired spatial learning and hyperactivity in developing rats exposed to intermittent hypoxia. Pediatr Res 2002; 52 (3) 449-453
• 207 Goldbart A, Cheng ZJ, Brittian KR, Gozal D. Intermittent hypoxia induces time-dependent changes in the protein kinase B signaling pathway in the hippocampal CA1 region of the rat. Neurobiol Dis 2003; 14 (3) 440-446
• 208 Gozal D, Row BW, Gozal E , et al. Temporal aspects of spatial task performance during intermittent hypoxia in the rat: evidence for neurogenesis. Eur J Neurosci 2003; 18 (8) 2335-2342
• 209 Kheirandish L, Row BW, Li RC, Brittian KR, Gozal D. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 2005; 28 (11) 1412-1417
• 210 Row BW, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 2003; 167 (11) 1548-1553
• 211 Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest 2012; 141 (6) 1601-1610
• 212 Quan SF, Chan CS, Dement WC , et al. The association between obstructive sleep apnea and neurocognitive performance—the Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep 2011; 34 (3) 303-314B
• 213 Kushida CA, Nichols DA, Holmes TH , et al. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep 2012; 35 (12) 1593-1602
• 214 Beebe DW, Groesz L, Wells C, Nichols A, McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep 2003; 26 (3) 298-307
• 215 Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc 2004; 10 (5) 772-785
• 216 Naismith S, Winter V, Gotsopoulos H, Hickie I, Cistulli P. Neurobehavioral functioning in obstructive sleep apnea: differential effects of sleep quality, hypoxemia and subjective sleepiness. J Clin Exp Neuropsychol 2004; 26 (1) 43-54
• 217 Bartlett DJ, Rae C, Thompson CH , et al. Hippocampal area metabolites relate to severity and cognitive function in obstructive sleep apnea. Sleep Med 2004; 5 (6) 593-596
• 218 Weng HH, Tsai YH, Chen CF , et al. Mapping gray matter reductions in obstructive sleep apnea: an activation likelihood estimation meta-analysis. Sleep 2014; 37 (1) 167-175
• 219 Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee?. Chest 2004; 126 (1) 1-2
• 220 Hopkins RO, Kesner RP, Goldstein M. Memory for novel and familiar spatial and linguistic temporal distance information in hypoxic subjects. J Int Neuropsychol Soc 1995; 1 (5) 454-468
• 221 Kesner RP, Hopkins RO. Short-term memory for duration and distance in humans: role of the hippocampus. Neuropsychology 2001; 15 (1) 58-68
• 222 Macey PM, Henderson LA, Macey KE , et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 166 (10) 1382-1387
• 223 Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002; 11 (1) 1-16
• 224 Canessa N, Castronovo V, Cappa SF , et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med 2011; 183 (10) 1419-1426
• 225 Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 2008; 275 (12) 2991-3002
• 226 Liu Y, Song X, Wang X , et al. Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. J Cell Biochem 2010; 111 (3) 554-563
• 227 Dewhirst MW. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 2007; 67 (3) 854-855
• 228 Cairns RA, Kalliomaki T, Hill RP. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res 2001; 61 (24) 8903-8908
• 229 Almendros I, Montserrat JM, Torres M , et al. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respir Physiol Neurobiol 2013; 186 (3) 303-307
• 230 Yamauchi M, Nakano H, Maekawa J , et al. Oxidative stress in obstructive sleep apnea. Chest 2005; 127 (5) 1674-1679
• 231 Almendros I, Wang Y, Becker L , et al. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med 2014; 189 (5) 593-601
• 232 Gharib SA, Seiger AN, Hayes AL, Mehra R, Patel SR. Treatment of obstructive sleep apnea alters cancer-associated transcriptional signatures in circulating leukocytes. Sleep 2014; 37 (4) 709-714 , 714A–714T
• 233 Christensen AS, Clark A, Salo P , et al. Symptoms of sleep disordered breathing and risk of cancer: a prospective cohort study. Sleep 2013; 36 (10) 1429-1435
• 234 Campos-Rodriguez F, Martinez-Garcia MA, Martinez M , et al; Spanish Sleep Network. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med 2013; 187 (1) 99-105
• 235 Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2012; 186 (2) 190-194